Patent Application
Utility
App. No. 09/798,088
· Confirmation No. 9311
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
View Patent ↗
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2001-05-02 | ABST |
Abstract | 1 | View | |
| 2001-03-02 | TRNA |
Transmittal of New Application | 1 | View | |
| 2001-03-02 | ADS |
Application Data Sheet | 2 | View | |
| 2001-03-02 | A.PE |
Preliminary Amendment | 7 | View | |
| 2001-03-02 | SPEC |
Specification | 63 | View | |
| 2001-03-02 | CLM |
Claims | 19 | View | |
| 2001-03-02 | ABST |
Abstract | 3 | View | |
| 2001-03-02 | OATH |
Oath or Declaration filed | 2 | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
549/200
C07D417/06
A61K31/343
A61K31/437
C07D307/80
C07D333/56
C07D471/04
C07D491/04
Prosecution
- Examiner
- SOLOLA, TAOFIQ A
- Art Unit
- 1626
- Docket No.
- AHP-98045 D1
- Confirmation No.
- 9311
Publication
- Pub. No.
- US20010053785A1
- Pub. Date
- 2001-12-20
Patent Term Adjustment
-75days
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 09/798,088
- Filed
- 2001-03-02
- Granted
- 2002-04-09
- Pub. No.
- US20010053785A1
- Examiner
- SOLOLA, TAOFIQ A
- Art Unit
- 1626
- PTA
- -75 days
External Links